Table 2.
Clinical characteristics of the study group (N = 80).
| Parameter | Total (N = 80) | |
|---|---|---|
| LVEF (%) | M ± SD | 44.54 ± 9.77 |
| Me | 43.5 | |
| Q1–Q3 | 37–51.75 | |
| HR (beats/minute) | M ± SD | 67.41 ± 8.46 |
| Me | 66.5 | |
| Q1–Q3 | 60–72 | |
| SBP (mmHg) | M ± SD | 134.57 ± 16.5 |
| Me | 137 | |
| Q1–Q3 | 122.25–143.25 | |
| DBP (mmHg) | M ± SD | 80.44 ± 11.07 |
| Me | 80 | |
| Q1–Q3 | 75–90 | |
| Duration of disease (years) | M ± SD | 3.5 ± 2.46 |
| Me | 3 | |
| Q1–Q3 | 1.75–5 | |
| NYHA class | NYHA I | 4 (5.00%) |
| NYHA II | 57 (71.25%) | |
| NYHA III | 19 (23.75%) | |
| Comorbidities | Diabetes | 48 (60.00%) |
| Ischemic heart disease | 58 (72.50%) | |
| Chronic obstructive pulmonary disease | 13 (16.25%) | |
| Chronic kidney disease | 27 (33.75%) | |
| Asthma | 6 (7.50%) | |
| Atrial fibrillation | 14 (17.50%) | |
| Hypertension | 60 (75.00%) | |
| Smoking | No | 46 (57.50%) |
| Yes | 34 (42.50%) | |
M ± SD, mean ± standard deviation; Me, median; Q, quartiles; LVEF, left ventricular ejection fraction; NYHA, New York Cardiovascular Association; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.